Effects of Pilates and Moderate-Intensity Aerobic Exercise on Postpartum Weight Loss and Body Composition
8. juni 2026 oppdatert av: Riphah International University
Effects of Pilates Versus Moderate Intensity Aerobic Exercises on Weight Loss, Body Mass Index and Waist to Hip Ratio in Postpartum Period.
After childbirth, many women experience difficulty losing pregnancy-related weight, which can affect their health, self-esteem, and physical activity.
Regular exercise, including Pilates and moderate-intensity aerobic exercises, is considered a safe and natural method to improve fitness and support weight loss during the postpartum period.
This study aims to compare the effects of Pilates and aerobic exercise on body weight, Body Mass Index (BMI), and waist-to-hip ratio in postpartum women over 8 weeks.
Participants will be randomly assigned to either a Pilates group or an aerobic exercise group, with both groups exercising three times weekly for 45-60 minutes.
The results will then be compared to determine which exercise method is more effective.
Studieoversikt
Status
Rekruttering
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
After childbirth, many women find it hard to lose the extra weight they gained during pregnancy. This weight can affect their health, self-esteem, and ability to stay active. Regular exercise is a safe and natural way to help lose weight and improve fitness during the postpartum period. Two popular forms of exercise are Pilates and moderate-intensity aerobic exercises (like brisk walking or cycling).
This study aims to find out which type of exercise-Pilates or aerobic exercise- is more helpful for postpartum women in reducing body weight, Body Mass Index (BMI), and waist-to-hip ratio over a period of 8 weeks. To do this, women will be randomly divided into two groups. One group will do Pilates exercises, and the other group will do aerobic exercises. Both groups will exercise three times a week for about 45-60 minutes each session. At the end of 8 weeks, the results will be compared to see which type of exercise is more effective.
Studietype
Intervensjonell
Registrering (Antatt)
30
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Imran Amjad, PHD*
- Telefonnummer: 03324390125
- E-post: imran.amjad@riphah.edu.pk
Studer Kontakt Backup
- Navn: Imran Amjad, PHD*
- Telefonnummer: 0515481826
- E-post: imran.amjad@riphah.edu.pk
Studiesteder
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Rekruttering
- Ghurki Teaching Hospital
-
Ta kontakt med:
- Ghulam Fatima, PhD*
- Telefonnummer: 03034073057
- E-post: ghulam.fatima@riphah.edu.pk
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Women aged 20 to 40 years
- BMI > 25kg/m2 at baseline
- Medically cleared by a health professional to perform physical activity
- Women 6 to 24 weeks postpartum
Exclusion Criteria:
- Women with complications during delivery (Cesarean complications, perineal tears grade 3 or 4)
- Presence of chronic disorders (diabetes mellitus, cardiovascular disorders, severe anemia)
- Neuromusculoskeletal disorders affecting physical activity
- Currently participating in another fitness program
- Postpartum depression or other psychological disorders that may affect adherence
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Group A - Pilates Group
Type of Exercise: Mat-based Pilates focusing on core stability, breathing control, flexibility, and pelvic floor strengthening
|
Pilates Group Type of Exercise: Mat-based Pilates focusing on core stability, breathing control, flexibility, and pelvic floor strengthening.
Structure: Warm-up (10 mins): Light mobility and breathing exercises; Main Session (30-40 mins): Pelvic tilts, bridging, leg stretches, roll-ups, side-lying series; Focus on posture, controlled movement, and core engagement; Cool-down (5-10 mins): Gentle stretching and relaxation.
Progression: Gradual increase in intensity and complexity over 8 weeks.
Supervision: Sessions led by a trained physiotherapist or certified Pilates instructor.
|
|
Aktiv komparator: Group B - Aerobic Exercise Group
Moderate intensity aerobic training (e.g., brisk walking, cycling, or low-impact dance routines) Intensity: 50-70% of maximum heart rate (monitored using Rate of Perceived Exertion Scale 11-13 on Borg Scale)
|
Aerobic Exercise Group Type of Exercise: Moderate intensity aerobic training (e.g., brisk walking, cycling, or low-impact dance routines).
Intensity: 50-70% of maximum heart rate (monitored using Rate of Perceived Exertion Scale 11-13 on Borg Scale).
Structure: Warm-up (10 mins): Marching in place, arm circles, step touch; Main Session (30-40 mins): Rhythmic aerobic routines or treadmill walking; Cool-down (5-10 mins): Stretching major muscle groups.
Supervision: Sessions conducted under the guidance of a physiotherapist or fitness instructor.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Weight (kilograms) - measured using a calibrated weighing scale
Tidsramme: 8 weeks
|
Measured with a calibrated digital weighing scale.
Participants will be weighed barefoot, wearing light clothing, after emptying their bladder.
Reliable if calibrated regularly and used under standardized conditions (same scale, same time of day, light clothing, after voiding).
Test-retest reliability > 0.97.
Highly valid for measuring body weight; directly measures mass in kilogram.
The scale's accuracy is typically within 0.1 kg.
|
8 weeks
|
|
Body Mass Index (BMI)
Tidsramme: 8 weeks
|
Calculated by dividing weight (kg) by the square of height (m) (BMI = weight/height²).
Height will be measured once at baseline with a stadiometer.
Reliable when the procedure is standardized (barefoot, standing straight, head in Frankfort plane).
Intra-observer reliability > 0.95.
Valid anthropometric tool; stadiometers accurately reflect true stature when calibrated.
|
8 weeks
|
|
Waist to Hip Ratio (WHR)
Tidsramme: 8 weeks
|
Calculated by dividing Waist by Hip (WHR = Waist cm / Hip cm).
Reliable if both waist and hip are measured accurately with the same procedure.
WHR is a well validated indicator of body-fat distribution and health-risk; a higher WHR is strongly associated with metabolic disorders
|
8 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Zainab Nadeem, MS*, Riphah International University
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Seitz D, Hintze A. [Myelomalacia following vertebral angiography with a femoral catheter (author's transl)]. Rofo. 1976 Jul;125(1):59-62. doi: 10.1055/s-0029-1230418. German.
- Goldstein J. Biologic and clinical considerations of hepatitis B infection. J Endod. 1979 Feb;5(2):56-9. doi: 10.1016/S0099-2399(79)80108-9. No abstract available.
- Drake AF, Dufton MJ, Hider RC. The flexible nature of a critical peptide region common to all Elapidae "short" neurotoxins. FEBS Lett. 1977 Nov 15;83(2):202-6. doi: 10.1016/0014-5793(77)81005-3. No abstract available.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
2. april 2025
Primær fullføring (Antatt)
2. september 2026
Studiet fullført (Antatt)
15. oktober 2026
Datoer for studieregistrering
Først innsendt
8. juni 2026
Først innsendt som oppfylte QC-kriteriene
8. juni 2026
Først lagt ut (Faktiske)
11. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
11. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
8. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- REC/RCR & AHS/25/0527
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .